Export 155 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria., J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
T. J. Krivanek, Gale, S. A., McFeeley, B. M., Nicastri, C. M., and Daffner, K. R., Promoting Successful Cognitive Aging: A Ten-Year Update., J Alzheimers Dis, vol. 81, no. 3, pp. 871-920, 2021.
R. Underlien Kristensen, Nørgaard, A., Jensen-Dahm, C., Gasse, C., Wimberley, T., and Waldemar, G., Polypharmacy and Potentially Inappropriate Medication in People with Dementia: A Nationwide Study., J Alzheimers Dis, vol. 63, no. 1, pp. 383-394, 2018.
K. Krishnan, Machulda, M. M., Whitwell, J. L., Butts, A. M., Duffy, J. R., Strand, E. A., Senjem, M. L., Spychalla, A. J., Jack, C. R., Lowe, V. J., and Josephs, K. A., Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity., J Alzheimers Dis, vol. 55, no. 3, pp. 1019-1029, 2017.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
K. Krishna, Behnisch, T., and Sajikumar, S., Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons., J Alzheimers Dis, vol. 51, no. 3, pp. 783-91, 2016.
J. Krell-Roesch, Syrjanen, J. A., Bezold, J., Trautwein, S., Barisch-Fritz, B., Boes, K., Woll, A., Forzani, E., Kremers, W. K., Machulda, M. M., Mielke, M. M., Knopman, D. S., Petersen, R. C., Vassilaki, M., and Geda, Y. E., Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
J. Krell-Roesch, Feder, N. T., Roberts, R. O., Mielke, M. M., Christianson, T. J., Knopman, D. S., Petersen, R. C., and Geda, Y. E., Leisure-Time Physical Activity and the Risk of Incident Dementia: The Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 63, no. 1, pp. 149-155, 2018.
J. Krell-Roesch, Ruider, H., Lowe, V. J., Stokin, G. B., Pink, A., Roberts, R. O., Mielke, M. M., Knopman, D. S., Christianson, T. J., Machulda, M. M., Jack, C. R., Petersen, R. C., and Geda, Y. E., FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 53, no. 4, pp. 1609-16, 2016.
W. Charles Kreisl, Jin, P., Lee, S., Dayan, E. R., Vallabhajosula, S., Pelton, G., Luchsinger, J. A., Pradhaban, G., and Devanand, D. P., Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults., J Alzheimers Dis, vol. 62, no. 4, pp. 1759-1766, 2018.
B. Krause-Sorio, Siddarth, P., Kilpatrick, L., Milillo, M. M., Aguilar-Faustino, Y., Ercoli, L., Narr, K. L., Khalsa, D. S., and Lavretsky, H., Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 87, no. 2, pp. 569-581, 2022.
A. Krasnianski, Bohling, G. T., Heinemann, U., Varges, D., Meissner, B., Schulz-Schaeffer, W. J., Reif, A., and Zerr, I., Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany., J Alzheimers Dis, vol. 59, no. 1, pp. 329-337, 2017.
J. Krämer, Lueg, G., Schiffler, P., Vrachimis, A., Weckesser, M., Wenning, C., Pawlowski, M., Johnen, A., Teuber, A., Wersching, H., Meuth, S. G., and Duning, T., Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia., J Alzheimers Dis, vol. 63, no. 1, pp. 239-253, 2018.
M. G. Kramberger, Auestad, B., Garcia-Ptacek, S., Abdelnour, C., Olmo, J. Garre, Walker, Z., Lemstra, A. W., Londos, E., Blanc, F., Bonanni, L., McKeith, I., Winblad, B., de Jong, F. Jan, Nobili, F., Stefanova, E., Petrova, M., Falup-Pecurariu, C., Rektorova, I., Bostantjopoulou, S., Biundo, R., Weintraub, D., and Aarsland, D., Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort., J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
B. Kramarz, Huntley, R. P., Rodríguez-López, M., Roncaglia, P., Saverimuttu, S. C. C., Parkinson, H., Bandopadhyay, R., Martin, M. - J., Orchard, S., Hooper, N. M., Brough, D., and Lovering, R. C., Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data., J Alzheimers Dis, vol. 75, no. 4, pp. 1417-1435, 2020.
I. Koychev, Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Rochester, L., Ffytche, D., Howard, R., Zetterberg, H., MacKay, C., and Lovestone, S., PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers., J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
I. Koychev, Galna, B., Zetterberg, H., Lawson, J., Zamboni, G., Ridha, B. H., Rowe, J. B., Thomas, A., Howard, R., Malhotra, P., Ritchie, C., Lovestone, S., and Rochester, L., Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study., J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
R. Kotani, Urano, Y., Sugimoto, H., and Noguchi, N., Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking., J Alzheimers Dis, vol. 56, no. 2, pp. 529-542, 2017.
K. Kostev, Hadji, P., and Jacob, L., Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany., J Alzheimers Dis, vol. 65, no. 2, pp. 401-407, 2018.
L. E. Korthauer, Awe, E., Frahmand, M., and Driscoll, I., Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age., J Alzheimers Dis, vol. 64, no. 2, pp. 459-471, 2018.
A. D. Korczyn, Dementia in the COVID-19 Period., J Alzheimers Dis, vol. 75, no. 4, pp. 1071-1072, 2020.
A. Koppara, Wolfsgruber, S., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., Peters, O., Reischies, F. M., Jahn, H., Luckhaus, C., Hüll, M., Gertz, H. - J., Schröder, J., Pantel, J., Rienhoff, O., Rüther, E., Henn, F., Wiltfang, J., Maier, W., Jessen, F., Kornhuber, J., and Wagner, M., The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 49, no. 2, pp. 547-60, 2016.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S., Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
D. Kontaxopoulou, Beratis, I. N., Fragkiadaki, S., Pavlou, D., Andronas, N., Yannis, G., Economou, A., Papanicolaou, A. C., and Papageorgiou, S. G., Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease., J Alzheimers Dis, vol. 65, no. 2, pp. 617-627, 2018.